Gilead Sciences
GILD
1,564 hedge funds and large institutions have $56.9B invested in Gilead Sciences in 2020 Q4 according to their latest regulatory filings, with 210 funds opening new positions, 520 increasing their positions, 688 reducing their positions, and 164 closing their positions.
28% more first-time investments, than exits
New positions opened: 210 | Existing positions closed: 164
2% more funds holding
Funds holding: 1,539 → 1,564 (+25)
0.41% less ownership
Funds ownership: 78.09% → 77.67% (-0.41%)
8% less capital invested
Capital invested by funds: $61.8B → $56.9B (-$4.92B)
16% less call options, than puts
Call options by funds: $1.44B | Put options by funds: $1.72B
22% less funds holding in top 10
Funds holding in top 10: 27 → 21 (-6)
24% less repeat investments, than reductions
Existing positions increased: 520 | Existing positions reduced: 688
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$275M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$272M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$155M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$112M |
| 5 |
Millennium Management
New York
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$398M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$239M |
| 3 |
Bank of New York Mellon
New York
|
-$158M |
| 4 |
AIG
American International Group
New York
|
-$131M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$122M |
GILD Hedge Fund Activity: Q4 2020 in Review
1,564 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2020, worth a combined $56.9B — down 8% from $61.8B a quarter earlier.
Buyers outnumbered sellers: 210 funds opened new GILD positions and 164 closed out — a net gain of 46 holders — while 520 added to existing stakes and 688 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $275M. The largest seller was BlackRock, cutting an estimated $398M.
- 1,564 institutional investors held Gilead Sciences (GILD) as of Q4 2020, up from 1,539 in Q3 2020.
- Funds reported $56.9B of Gilead Sciences stock for Q4 2020, down 8% quarter-over-quarter.
- 210 funds opened new Gilead Sciences positions in Q4 2020 and 164 closed out, a net change of +46 holders.
- The largest Gilead Sciences buyer in Q4 2020 was Capital Research Global Investors, an estimated $275M added.
- The largest Gilead Sciences seller in Q4 2020 was BlackRock, an estimated $398M sold.
Based on aggregated 13F filings for Q4 2020.